[Stan K]

I find it a little inappropriate when someone that’s a thought leader in the hernia space, particularly in a forum that I thought was objective, is plugging a product such as Ovitex by Telabio when the surgeon has significant equity in the company and is paid thousands to “consult” for them. This seems like a big conflict of interest.

If everyone pushes the product they are paid to use, how are we to make real advances in mesh design? It is a truism that for every statistic in the surgical literature, there is an equal and opposite statistic in the same literature.

-Stan

[Stan K]

The biggest challenge facing this mesh conundrum is that data and research have become works of fiction dictated by industry lobbyist. False findings are the majority. Surgeon’s use the mesh by the company that pays them to “consult” and because of this there is extreme bias, which I believe is significantly holding the industry back from making real advancements in mesh design. The current paradigm searches for a solution based off false scientific rationale, driven by the messaging of the mesh companies. Capitalism at it’s finest.